Kevin Eggan
This article may have been previously nominated for deletion: Wikipedia:Articles for deletion/Kevin Eggan exists. It is proposed that this article be deleted because of the following concern:
If you can address this concern by improving, copyediting, sourcing, renaming, or merging the page, please edit this page and do so. You may remove this message if you improve the article or otherwise object to deletion for any reason. Although not required, you are encouraged to explain why you object to the deletion, either in your edit summary or on the talk page. If this template is removed, do not replace it. This message has remained in place for seven days, so the article may be deleted without further notice. Find sources: "Kevin Eggan" – news · newspapers · books · scholar · JSTOR Nominator: Please consider notifying the author/project: {{subst:proposed deletion notify|Kevin Eggan|concern=Insufficient evidence of notability.}} ~~~~Timestamp: 20070902032518 03:25, 2 September 2007 (UTC) Administrators: delete |
Kevin Eggan (born 1975 in Normal, Illinois) is a cellular biologist at Harvard University currently involved in stem cell research. Eggan runs the Kevin Eggan Lab at Harvard as Assistant Professor of Molecular and Cellular Biology.
Education
Eggan completed a bachelor’s degree in microbiology from the University of Illinois. He applied to medical school, was accepted, but deferred in favor of a two-year research stint at the National Institutes of Health. He pursued a PhD at the Massachusetts Institute of Technology for fall entry in 1998.
Eggan began to explore this process and also the more ominous finding that cloned animals often develop abnormally, with organ defects and immunological problems. After finishing his PhD in 2002, Eggan split his time between a postdoc with Jaenisch and a collaborative project with Richard Axel, a Nobel Prize–winning scientist at the Howard Hughes Medical Institute.
In August 2004, Eggan came to Harvard to begin a junior fellowship. Now Kevin Eggan is an assistant professor of Molecular & Cellular Biology and assistant investigator of Stowers Medical Institute.
In 2006, Eggan initially worked with Melton on diabetes, and then planned to focus on neurodegenerative diseases, such as amyotrophic lateral sclerosis (ALS) - better known as Lou Gehrig's disease. [1]
Stem Cell Research
Eggan says his research goals at Harvard are twofold: One is to understand how nuclear transplantation actually works, and the other is to make stem cells that carry genes for specific diseases. He hopes to use these cells to study neurodegenerative illnesses like Parkinson’s disease, Lou Gehrig’s disease, and Alzheimer’s.[2]
Harvard scientists have created cells similar to human embryonic stem cells without destroying embryos, a major step toward someday possibly defusing the central objection to stem cell research.[3]
Professional Career
Eggan has authored many journal and magazine articles on stem cell research, some of them include.[4]
- Non-cell autonomous effect of glia on motor neurons in an embryonic stem cell-based ALS model.
- Wagers AJ. Ovulated oocytes in adult mice derive from non-circulating germ cells, in Nature June 29 2006.
- Nuclear reprogramming of somatic cells after fusion with human embryonic stem cells, in Science Aug 26, 2005.